G Medical Innovations Holdings Ltd [GMVD] Stock trading around $0.40 per share: What’s Next?

G Medical Innovations Holdings Ltd [NASDAQ: GMVD] traded at a high on 08/18/22, posting a 3.72 gain after which it closed the day’ session at $0.40. The company report on July 13, 2022 that G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick results.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for purchasing by consumers during Q3-2022 online as well as at popular retail locations and pharmacies.

The tests offered to the consumers utilize FDA registered components.

The results of the trading session contributed to over 2378422 shares changing hands. Over the past one week, the price volatility of G Medical Innovations Holdings Ltd stands at 9.08% while the volatility over the past one month is 11.33%.

The market cap for GMVD stock reached $5.37 million, with 13.46 million shares outstanding. Compared to the average trading volume of 2.81M shares, GMVD reached a trading volume of 2378422 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about G Medical Innovations Holdings Ltd [GMVD]?

The Average True Range (ATR) for G Medical Innovations Holdings Ltd is set at 0.06, with the Price to Sales ratio for GMVD stock in the period of the last 12 months amounting to 1.06. The Price to Book ratio for the last quarter was 1.59.

How has GMVD stock performed recently?

G Medical Innovations Holdings Ltd [GMVD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.80. With this latest performance, GMVD shares dropped by -5.58% in over the last four-week period, additionally sinking by -86.52% over the last 6 months – not to mention a drop of -83.02% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GMVD stock in for the last two-week period is set at 42.61, with the RSI for the last a single of trading hit 45.41, and the three-weeks RSI is set at 42.11 for G Medical Innovations Holdings Ltd [GMVD]. The present Moving Average for the last 50 days of trading for this stock 0.5558, while it was recorded at 0.3888 for the last single week of trading, and 1.6705 for the last 200 days.

G Medical Innovations Holdings Ltd [GMVD]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and G Medical Innovations Holdings Ltd [GMVD] shares currently have an operating margin of -222.80 and a Gross Margin at +19.77. G Medical Innovations Holdings Ltd’s Net Margin is presently recorded at -291.78.

Insider trade positions for G Medical Innovations Holdings Ltd [GMVD]

There are presently around $0 million, or 1.26% of GMVD stock, in the hands of institutional investors. The top three institutional holders of GMVD stocks are: SCHONFELD STRATEGIC ADVISORS LLC with ownership of 121,100, which is approximately 3.416% of the company’s market cap and around 21.39% of the total institutional ownership; GOLDMAN SACHS GROUP INC, holding 65,336 shares of the stock with an approximate value of $26000.0 in GMVD stocks shares; and JPMORGAN CHASE & CO, currently with $24000.0 in GMVD stock with ownership of nearly 0% of the company’s market capitalization.

7 institutional holders increased their position in G Medical Innovations Holdings Ltd [NASDAQ:GMVD] by around 108,884 shares. Additionally, 6 investors decreased positions by around 197,878 shares, while 4 investors held positions by with 75,756 shares. The mentioned changes placed institutional holdings at 382,518 shares, according to the latest SEC report filing. GMVD stock had 4 new institutional investments in for a total of 83,206 shares, while 4 institutional investors sold positions of 164,521 shares during the same period.


Please enter your comment!
Please enter your name here